Melanoma
2 competing products in clinical development for Melanoma.
Pipeline by Phase
Phase 11
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tasisulam-sodium + Paclitaxel | Eli Lilly | Phase 3 | Terminated | 77 |
| Binimetinib Oral Tablet | Biotrial | Phase 1 | UNKNOWN | 25 |